Utah Medical Products, Inc.
Utah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings…
1D
-0.5%
1W
-0.0%
1M
+0.6%
6M
+5.5%
YTD
+33.1%
1Y
+24.0%
2Y
+12.4%
5Y
-17.2%
10Y
+20.9%
Next earnings date
22/10/2026 (in 5 days)
Volatility around earnings
~1% weaker price swings than usual
P/E
22.72
P/B
1.94
EV/EBITDA
16.09
RETURN ON EQUITY
2.2%
NET MARGIN
31.5%
DEBT/EQUITY
0
DIVIDEND YIELD
1.7%
AS OF
30/06/2026
FREE FLOAT
87.6%
FLOAT SHARES
2,779,823
AVG. DAILY VOLUME (30D)
37,457
RICHINS PAUL O
Koopman Brian
Utah Medical Products, Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is Kevin L. Cornwell, the company employs around 146 people.
The IPO was on 08/03/1999; the stock trades on NASDAQ under the ticker UTMD.
The next earnings date is 22/10/2026.
Around past earnings, price swings were roughly -1% stronger than usual.
Yes. The last dividend was US$0.31 per share, ex-date 17/09/2026, paid on 05/10/2026.
The dividend yield is 1.7% (as of 30/06/2026).
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies and Avantor.
Clicking "Analyze stock" lets five strategies assess Utah Medical Products against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.